NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Ketamine has emerged as a widespread treatment for a variety of psychiatric disorders when used at sub-anesthetic doses, but the neural mechanisms underlying its acute action remain unclear. Here, we identified NMDA receptors containing the 2A subunit (GluN2A) on parvalbumin (PV)-expressing inhibitory interneurons as a pivotal target of low-dose ketamine. Genetically deleting GluN2A receptors globally or selectively from PV interneurons abolished the rapid enhancement of visual cortical responses and gamma-band oscillations by ketamine. Moreover, during the follicular phase of the estrous cycle in female mice, the ketamine response was transiently attenuated along with a concomitant decrease of grin2A mRNA expression within PV interneurons. Thus, GluN2A receptors on PV interneurons mediate the immediate actions of low-dose ketamine treatment, and fluctuations in receptor expression across the estrous cycle may underlie sex-differences in drug efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“GluN2A containing NMDARs in PV interneurons are necessary for the rapid actions of ketamine on evoked firing of visual cortex pyramidal neurons and gamma-band oscillations in mice (Picard et al., 2019).”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Picard et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
Parvalbumin neurons and gamma rhythms enhance cortical circuit performance
Sohal, V. S., Zhang, F., Yizhar, O., & Deisseroth, K. (2009) · Nature · doi:10.1038/nature07991 · Cited by 2,606
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Paoletti, P., Bellone, C., & Zhou, Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3504 · Cited by 2,523
Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks
Bartos, M., Vida, I., & Jonas, P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2044 · Cited by 2,070
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609
Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related Drugs
Olney, J. W., Labruyere, J., & Price, M. T. (1989) · Science · doi:10.1126/science.2660263 · Cited by 1,237
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
Highly selective receptive fields in mouse visual cortex
Niell, C. M., & Stryker, M. P. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0623-08.2008 · Cited by 1,081
Ketamine blocks bursting in the lateral habenula to rapidly relieve depression
Yang, Y., Cui, Y., Sang, K., Dong, Y., Ni, Z., Ma, S., & Hu, H. (2018) · Nature · doi:10.1038/nature25509 · Cited by 1,036
NMDA receptor hypofunction model of schizophrenia
Olney, J. W., Newcomer, J. W., & Farber, N. B. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00029-1 · Cited by 1,020
Gender differences in depression
Parker, G., & Brotchie, H. (2010) · International Review of Psychiatry · doi:10.3109/09540261.2010.492391 · Cited by 756
Activity-Dependent Decrease in NMDA Receptor Responses During Development of the Visual Cortex
Carmignoto, G., & Vicini, S. (1992) · Science · doi:10.1126/science.1279803 · Cited by 716
Woolley, C. S., Weiland, N. G., McEwen, B. S., & Schwartzkroin, P. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01848.1997 · Cited by 690
McLean, A. C., Valenzuela, N., Fai, S., & Bennett, S. A. L. (2012) · Journal of Visualized Experiments · doi:10.3791/4389 · Cited by 644 · cited 2×
“Females were classified in two groups: (1) follicular phase (Estrus+ Proestrus) when estradiol concentration is low, and (2) luteal phase (Metestrus+Diestrus) when estradiol concentration is high [33, 52].”
BackgroundMethodAntidepressant effect of optogenetic stimulation of the medial prefrontal cortex
Covington, H. E., Lobo, M. K., Maze, I., Vialou, V., Hyman, J. M., Zaman, S., LaPlant, Q., Mouzon, E., Ghose, S., Tamminga, C. A., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1731-10.2010 · Cited by 621
Feder, A., Parides, M. K., Murrough, J. W., Perez, A. M., Morgan, J. E., Saxena, S., Kirkwood, K., aan het Rot, M., Lapidus, K. A. B., Wan, L.-B., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.62 · Cited by 613
Price, R. B., Nock, M. K., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.029 · Cited by 600
Glutamate as a therapeutic target in psychiatric disorders
Javitt, D. C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001551 · Cited by 524
Perineuronal nets protect fast-spiking interneurons against oxidative stress
Cabungcal, J.-H., Steullet, P., Morishita, H., Kraftsik, R., Cuenod, M., Hensch, T. K., & Do, K. Q. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300454110 · Cited by 512
Self-citationNMDA-dependent modulation of CA1 local circuit inhibition
Grunze, H., Rainnie, D., Hasselmo, M., Barkai, E., Hearn, E., McCarley, R., & Greene, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-02034.1996 · Cited by 467
Kapur, S., & Seeman, P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001093 · Cited by 459
Wong, M., & Moss, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-08-03217.1992 · Cited by 457
Garcia, L. S. B., Comim, C. M., Valvassori, S. S., Réus, G. Z., Barbosa, L. M., Andreazza, A. C., Stertz, L., Fries, G. R., Gavioli, E. C., Kapczinski, F., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.027 · Cited by 454
Wenzel, A., Fritschy, J. M., Mohler, H., & Benke, D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020469.x · Cited by 441
Sex differences in anxiety and emotional behavior
Donner, N. C., & Lowry, C. A. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1271-7 · Cited by 379
Differential Regulation of NMDAR1 mRNA and Protein by Estradiol in the Rat Hippocampus
Gazzaley, A. H., Weiland, N. G., McEwen, B. S., & Morrison, J. H. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-21-06830.1996 · Cited by 375
Miller, O. H., Yang, L., Wang, C.-C., Hargroder, E. A., Zhang, Y., Delpire, E., & Hall, B. J. (2014) · eLife · doi:10.7554/elife.03581 · Cited by 358
Gender differences in susceptibility to posttraumatic stress disorder
Stein, M. B., Walker, J. R., & Forde, D. R. (2000) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(99)00098-4 · Cited by 356
Kinney, J. W., Davis, C. N., Tabarean, I., Conti, B., Bartfai, T., & Behrens, M. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4722-05.2006 · Cited by 329
Pinault, D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.006 · Cited by 315 · cited 1×
“Ketamine at low doses is well known to modulate neuronal oscillatory activity in humans and rodents [17, 18, 35].”
BackgroundGray, J. A., Shi, Y., Usui, H., During, M. J., Sakimura, K., & Nicoll, R. A. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.007 · Cited by 303
Meyer, A. H., Katona, I., Blatow, M., Rozov, A., & Monyer, H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07055.2002 · Cited by 293
Hong, L. E., Summerfelt, A., Buchanan, R. W., O'Donnell, P., Thaker, G. K., Weiler, M. A., & Lahti, A. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.168 · Cited by 274
NMDA receptor channels: Subunit-specific potentiation by reducing agents
Köhr, G., Eckardt, S., Lüddens, H., Monyer, H., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90311-5 · Cited by 257
Sex differences in the antidepressant-like effects of ketamine
Carrier, N., & Kabbaj, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.12.009 · Cited by 251
Muthukumaraswamy, S. D., Shaw, A. D., Jackson, L. E., Hall, J., Moran, R., & Saxena, N. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0903-15.2015 · Cited by 234
The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
Abdallah, C. G., De Feyter, H. M., Averill, L. A., Jiang, L., Averill, C. L., Chowdhury, G. M. I., Purohit, P., de Graaf, R. A., Esterlis, I., Juchem, C., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0136-3 · Cited by 229
Hakami, T., Jones, N. C., Tolmacheva, E. A., Gaudias, J., Chaumont, J., Salzberg, M., O'Brien, T. J., & Pinault, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006755 · Cited by 228 · cited 1×
“Ketamine at low doses is well known to modulate neuronal oscillatory activity in humans and rodents [17, 18, 35].”
BackgroundBelujon, P., & Grace, A. A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.014 · Cited by 225
Fuchs, T., Jefferson, S. J., Hooper, A., Yee, P.-H., Maguire, J., & Luscher, B. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.188 · Cited by 204
Widman, A. J., & McMahon, L. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718883115 · Cited by 204
Cell Type-Specific Development of NMDA Receptors in the Interneurons of Rat Prefrontal Cortex
Wang, H.-X., & Gao, W.-J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.20 · Cited by 203 · cited 1×
“Mature NMDA currents recorded in cortical PV cells are primarily mediated by 2A subunits [24, 40].”
BackgroundBidirectional plasticity in fast-spiking GABA circuits by visual experience
Yazaki-Sugiyama, Y., Kang, S., Câteau, H., Fukai, T., & Hensch, T. K. (2009) · Nature · doi:10.1038/nature08485 · Cited by 200
Self-citationFranceschelli, A., Sens, J., Herchick, S., Thelen, C., & Pitychoutis, P. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.008 · Cited by 198
Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain
Morissette, M., Le Saux, M., D’Astous, M., Jourdain, S., Al Sweidi, S., Morin, N., Estrada-Camarena, E., Mendez, P., Garcia-Segura, L. M., & Di Paolo, T. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.09.011 · Cited by 188
Fagiolini, M., Katagiri, H., Miyamoto, H., Mori, H., Grant, S. G. N., Mishina, M., & Hensch, T. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0536089100 · Cited by 178
Self-citationKocsis, B. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.002 · Cited by 159
Takahata, R., & Moghaddam, B. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300127 · Cited by 152
Potentiation of μ‐opioid receptor‐mediated signaling by ketamine
Gupta, A., Devi, L. A., & Gomes, I. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07361.x · Cited by 132
Li, Q., Clark, S., Lewis, D. V., & Wilson, W. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03070.2002 · Cited by 132
El-Bakri, N., Islam, A., Zhu, S., Elhassan, A. M., Mohammed, A. K., Winblad, B. G., & Adem, A. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00478.x · Cited by 115
Romeo, R. D., McCarthy, J. B., Wang, A., Milner, T. A., & McEwen, B. S. (2005) · Neuroendocrinology · doi:10.1159/000089557 · Cited by 115
Middleton, S., Jalics, J., Kispersky, T., LeBeau, F. E. N., Roopun, A. K., Kopell, N. J., Whittington, M. A., & Cunningham, M. O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809302105 · Cited by 113
Jelks, K. B., Wylie, R., Floyd, C. L., McAllister, A. K., & Wise, P. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0909-07.2007 · Cited by 111
Robson, M. J., Elliott, M., Seminerio, M. J., & Matsumoto, R. R. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.002 · Cited by 110
Patrizi, A., Picard, N., Simon, A. J., Gunner, G., Centofante, E., Andrews, N. A., & Fagiolini, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.018 · Cited by 100
Self-citationTherapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
Jaso, B. A., Niciu, M. J., Iadarola, N. D., Lally, N., Richards, E. M., Park, M., Ballard, E. D., Nugent, A. C., Machado-Vieira, R., & Zarate, C. A. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160321123221 · Cited by 98
Memantine binding to a superficial site on NMDA receptors contributes to partial trapping
Kotermanski, S. E., Wood, J. T., & Johnson, J. W. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.176297 · Cited by 92
Xi, D., Zhang, W., Wang, H.-X., Stradtman, G. G., & Gao, W.-J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570900042x · Cited by 83 · cited 1×
“Thus, fluctuations in estradiol might mediate the variable sensitivity to ketamine and other NMDA receptor antagonists in females [50].”
BackgroundPozzi, L., Dorocic, I. P., Wang, X., Carlén, M., & Meletis, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083879 · Cited by 74
Sapkota, K., Mao, Z., Synowicki, P., Lieber, D., Liu, M., Ikezu, T., Gautam, V., & Monaghan, D. T. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.230391 · Cited by 70
Xi, D., Keeler, B., Zhang, W., Houle, J. D., & Gao, W.-J. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.09.013 · Cited by 66
Grent-‘t-Jong, T., Rivolta, D., Gross, J., Gajwani, R., Lawrie, S. M., Schwannauer, M., Heidegger, T., Wibral, M., Singer, W., Sauer, A., et al. (2018) · Brain · doi:10.1093/brain/awy175 · Cited by 66
Charitidi, K., Meltser, I., & Canlon, B. (2012) · Endocrinology · doi:10.1210/en.2012-1416 · Cited by 64
Sensory-driven and spontaneous gamma oscillations engage distinct cortical circuitry
Welle, C. G., & Contreras, D. (2015) · Journal of Neurophysiology · doi:10.1152/jn.00137.2015 · Cited by 60
Dominguez, R., Liu, R., & Baudry, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04360.x · Cited by 56 · cited 2×
“Estrogen modulation of NMDA receptor activity and sensitivity involves extranuclear estrogen receptors (ER) [45, 47, 72], including potential activation of several signaling pathways such as ERK and Akt which phosphorylate NMDA receptor subunits [47].”
BackgroundMcNally, J. M., McCarley, R. W., McKenna, J. T., Yanagawa, Y., & Brown, R. E. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.015 · Cited by 56
Rybakowski, J. K., Permoda-Osip, A., & Bartkowska-Sniatkowska, A. (2017) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2017.1297834 · Cited by 52
Cell-Specific Regulation of N-Methyl-D-Aspartate Receptor Maturation by Mecp2 in Cortical Circuits
Mierau, S. B., Patrizi, A., Hensch, T. K., & Fagiolini, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.018 · Cited by 50
Self-citationGlutamate receptors as therapeutic targets
Javitt, D. C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001602 · Cited by 42
Sullivan, E. M., Timi, P., Hong, L. E., & O’Donnell, P. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.228 · Cited by 41
Borella, V., Seeman, M. V., Cordeiro, R. C., Santos, J. V. D., de Souza, M. R. M., Fernandes, E. N. D. S., Monte, A. S., Vasconcelos, S. M. M., Quinn, J. P., de Lucena, D. F., et al. (2015) · Developmental Neurobiology · doi:10.1002/dneu.22329 · Cited by 35
Ebine, T., Toriumi, H., Shimizu, T., Unekawa, M., Takizawa, T., Kayama, Y., Shibata, M., & Suzuki, N. (2016) · Neuroscience Research · doi:10.1016/j.neures.2016.06.001 · Cited by 33
Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior
Mallick, F., & McCullumsmith, C. B. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0680-7 · Cited by 22 · cited 1×
“Low-dose ketamine in adulthood has been shown to produce antidepressant effects [1–5] and to relieve suicidal ideation [6] or post-traumatic disorders [7].”
BackgroundCarceller, H., Pérez-Rando, M., Ċastrén, E., Nácher, J., & Guirado, R. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.06.041 · Cited by 15
Behr, G. A., da Motta, L. L., de Oliveira, M. R., Oliveira, M. W. S., Hoff, M. L. M., Silvestrin, R. B., & Moreira, J. C. F. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.047 · Cited by 11
Cited by
Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action
Castrén, E., & Monteggia, L. M. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.008 · Cited by 540
The origin of NMDA receptor hypofunction in schizophrenia
Nakazawa, K., & Sapkota, K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107426 · Cited by 275
“…(PV)-positive neuron-specific genetic ablation of GluN2A, which is highly expressed in GABA neurons, was also sufficient to ablate ketamine-induced changes in pyramidal cell activity in mouse visual cortex, suggesting that ketamine binds to GluN2A-containing PV neurons (Picard et al., 2019).”
BackgroundMechanisms of ketamine and its metabolites as antidepressants
Hess, E. M., Riggs, L. M., Michaelides, M., & Gould, T. D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114892 · Cited by 175
Chari, T., Griswold, S., Andrews, N. A., & Fagiolini, M. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00113 · Cited by 164
Self-citationVenturino, A., Schulz, R., De Jesús-Cortés, H., Maes, M. E., Nagy, B., Reilly-Andújar, F., Colombo, G., Cubero, R. J. A., Schoot Uiterkamp, F. E., Bear, M. F., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109313 · Cited by 140
Metadata
- Authors
- Picard, N., Takesian, A. E., Fagiolini, M., & Hensch, T. K.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- Fagiolini, Michela
- Hensch, Takao K.
- Venue
- Molecular Psychiatry
- Published
- 2019-01-29
- Volume
- 24
- Issue
- 6
- Pages
- 828-838
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC6756203
- OpenAlex
- W2911866952
- Cited by
- 71
- References
- 77
- Citations by year
- 2026: 14 · 2025: 7 · 2024: 7 · 2023: 7 · 2022: 6 · 2021: 13 · 2020: 14 · 2019: 3
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Molecular Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (1P50MH094271)
- Pfizer
- Nancy Lurie Marks Family Foundation
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01 NS095959)
- U.S. Department of Health & Human Services | NIH | National Eye Institute (R01 EY013613)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- NMDA receptor, GluN2A, parvalbumin interneurons, ketamine, sex differences, estrous cycle, gamma oscillations, visual cortex, cortical responses, GRIN2A, inhibitory interneurons, low-dose ketamine
- MeSH terms
- Animals, Female, Interneurons, Ketamine, Male, Mice, Inbred C57BL, Parvalbumins, Receptors, GABA-A, Sex Factors, Receptors, N-Methyl-D-Aspartate, N-Methylaspartate, Prefrontal Cortex, Estrous Cycle, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.